1. Home
  2. CASS vs SGP Comparison

CASS vs SGP Comparison

Compare CASS & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

HOLD

Current Price

$52.04

Market Cap

675.9M

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$22.62

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
SGP
Founded
1906
2019
Country
United States
United States
Employees
N/A
65
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.9M
650.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CASS
SGP
Price
$52.04
$22.62
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$45.00
$45.00
AVG Volume (30 Days)
87.1K
155.2K
Earning Date
04-23-2026
05-15-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
N/A
EPS
0.67
N/A
Revenue
$190,750,000.00
N/A
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$77.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$17.06
52 Week High
$53.19
$30.56

Technical Indicators

Market Signals
Indicator
CASS
SGP
Relative Strength Index (RSI) 64.00 61.57
Support Level $45.19 $20.95
Resistance Level $52.82 $22.80
Average True Range (ATR) 1.36 1.74
MACD -0.01 0.31
Stochastic Oscillator 74.81 93.20

Price Performance

Historical Comparison
CASS
SGP

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: